Influence of phlebotomy on iron-related gene expression levels in the livers of patients with chronic hepatitis C [2]

Journal of Gastroenterology

Volumn 42, Issue 4, 2007, Pages 326-327

  Fujita, Naoki ^a,b   Sugimoto, Ryosuke ^a   Urawa, Naohito ^a   Tanaka, Hideaki ^a   Konishi, Masayoshi ^c   Kobayashi, Yoshinao ^a   Iwasa, Motoh ^a   Watanabe, Shozo ^c   Kaito, Masahiko ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b National Hospital Organization Mie Chuo Medical Center   (Japan)

^c MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CD71 ANTIGEN; FERRITIN; FERROPORTIN 1; GLYCERALDEHYDE 3 PHOSPHATE; HEPCIDIN; IRON; MESSENGER RNA; TRANSFERRIN RECEPTOR 2;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; GENE EXPRESSION; HEPATITIS C; HUMAN; IRON METABOLISM; IRON OVERLOAD; LETTER; LIVER BIOPSY; MALE; PHLEBOTOMY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ADULT; AGED; ANTIGENS, CD; ANTIMICROBIAL CATIONIC PEPTIDES; FEMALE; FERRITINS; GENE EXPRESSION REGULATION; HEPATITIS C, CHRONIC; HUMANS; IRON OVERLOAD; LIVER; MALE; MIDDLE AGED; PHLEBOTOMY; RECEPTORS, TRANSFERRIN; RNA, MESSENGER;

EID: 34247635723     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-007-2004-5     Document Type: Letter

References (9)

1. HL Bonkovsky BF Banner AL Rothman 1997 Iron and chronic viral hepatitis Hepatology 25 759-68 9049232 10.1002/hep.510250345 1:STN:280:ByiB3c7ksVI%3D
2. HL Bonkovsky 1997 Therapy of hepatitis C: Other options Hepatology 26 Suppl 143S-51S 9305680 10.1002/hep.510260725 1:CAS:528:DyaK2sXmt1CktLg%3D
3. M Yano H Hayashi K Yoshioka Y Kohgo H Saito Y Niitsu 2004 A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: A multicenter, prospective, randomized, controlled trial in Japan J Gastroenterol 39 570-4 15235875 10.1007/s00535-003-1344-z 1:CAS:528:DC%2BD2cXlt1ylsLk%3D
4. Y Kawamura N Akuta H Sezaki T Hosaka T Someya M Kobayashi 2005 Determinants of serum ALT normalization after phlebotomy in patients with chronic hepatitis C infection J Gastroenterol 40 901-6 16211347 10.1007/s00535-005-1636-6
5. RE Fleming BR Bacon 2005 Orchestration of iron homeostasis N Engl J Med 352 1741-4 15858181 10.1056/NEJMp048363 1:CAS:528:DC%2BD2MXjsFyiurY%3D
6. M Takeo Y Kobayashi N Fujita N Urawa M Iwasa S Horiike 2005 Upregulation of transferrin receptor 2 and ferroportin 1 mRNA in the liver of patients with chronic hepatitis C J Gastroenterol Hepatol 20 562-9 15836704 10.1111/j.1440-1746.2005.03770.x 1:CAS:528:DC%2BD2MXls1aqt70%3D
7. T Ganz 2003 Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation Blood 102 783-8 12663437 10.1182/ blood-2003-03-0672 1:CAS:528:DC%2BD3sXlvFCms7g%3D
8. DM Frazer SJ Wilkins EM Becker CD Vulpe AT Mckie D Trinder 2002 Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats Gastroenterology 123 835-44 12198710 10.1053/gast.2002.35353 1:CAS:528:DC%2BD38Xntl2murs%3D
9. E Nemeth MS Tuttle J Powelson MB Vaughn A Donovan DM Ward 2004 Hepcidin regulates iron efflux by binding to ferroportin and inducing its internalization Science 306 2090-3 15514116 10.1126/science.1104742 1:CAS:528:DC%2BD2cXhtVOjsL3K